Clinical Trial Update: TEsting METformin Against Cognitive Decline in HD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating metformin for cognitive decline in Huntington's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Instituto de Investigacion Sanitaria La Fe | Conditions: Huntington Disease | Phase 3 | Status: COMPLETED